Corporate Giving

Biogen’s global grants and giving strategy aims to catalyze scientific innovation, address unmet patient needs, and advance medical and disease education through funding a variety of programs and initiatives.

We are pleased to share that our grant application portal will be open for submissions as of May 1, 2024. At this time, we will only be accepting applications which meet specific criteria: 

• Only Grant Applications outside of North America will be accepted in 2024.
• Applications must be related to one of the following disease areas: Spinal Muscular Atrophy (SMA), Friedreich’s ataxia (FA), Amyotrophic Lateral Sclerosis (ALS)

We are continuously reviewing and evaluating our global grants strategy and will modify the above-mentioned criteria accordingly.

• Grants: Financial contributions provided to eligible organizations to support specific, time-limited projects or programs with identified objectives, without tangible benefit to Biogen in return.
  • Medical Education: Funding to an eligible institution or organization to support independent medical educational activities for HCPs and researchers. Medical Education may be accredited or non-accredited.
  • Patient Education: Funding to an eligible institution or organization to support independent educational activities for patients or caregivers.
  • Fellowships: Funding for training programs created by medical schools, academic medical centers, teaching hospitals, or other healthcare-related organizations to support faculty and visiting scholars to advance their educational and research activities.
  • Infrastructure: Funding for infrastructure upgrades for healthcare organizations or institutions.                                 
  • General: Funding to support a project or program that does not fit any of the other defined grant categories.
• Sponsorships: Financial contributions provided to eligible organizations in connection with specific events or initiatives in exchange for tangible benefit to Biogen.

Biogen supports medical research that advances scientific knowledge of disorders relevant to our therapeutic portfolio and products aimed toward improving the quality of patient care.

The following study types are considered for medical research support:

• Investigator-Initiated Research (IIR): An unsolicited preclinical, clinical, outcomes- or disease-state-related study independently generated by an investigator.
• Collaborative Research (CR): A collaboration between Biogen and an investigator on a research proposal. Biogen and the investigator collaborate on the study and the interpretation of the results.